Furthermore, a recent study also demonstrates that targeting Gas6 and TAM receptors with either specific antibodies directed at Gas6 or Axl or with small-molecule TAM inhibitors attenuates the activation of pulmonary fibroblasts in idiopathic pulmonary fibrosis [33]. This evidence concerns the gene GAS6 and idiopathic pulmonary fibrosis.